Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesEnvista Holdings Corp

Envista Holdings Corp

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
25.17 USD 0.21 ( 0.84%)
Last update at 2026-11-06T21:00:00Z
VOLUME
3234787
Market Cap
3972.08M
P/E
44.16

Momentum Score

…

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
24.13
Low
25.27
High
52 Week Price Range
18.77
Low
30.42
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Envista Holdings is a global dental products and technology company supplying implants, restorative materials, devices, imaging systems and consumables to dental professionals. Long-term growth may be supported by ageing populations, greater dental service demand, adoption of digital dentistry and recurring consumables sales; investors may find appeal in its diversified product mix and exposure to structural dental-care trends.
Material risks include strong competition from larger dental companies, execution risk on new products and acquisitions, and sensitivity of procedure volumes to economic, currency and regulatory shifts that investors should monitor.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
24.96
Dividend Yield
-
Revenue TTM
2856.50M
Revenue Per Share
17.41
Gross Profit TTM
1583.10M
Debt / Equity
0.51
ROE
3.06%
Net Debt
386.00M
ROCE
4.43%
Diluted EPS TTM
0.56

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 177.20M -1084.70M -54.90M 283.90M 254.50M
Net income 47.00M -1118.60M -100.20M 243.10M 263.50M
Selling general administrative 1136.90M 1136.40M 1050.30M 1055.50M 1019.80M
Gross profit 1496.30M 1391.60M 1440.50M 1474.80M 1426.50M
Reconciled depreciation 150.70M 154.50M 164.90M 162.10M 151.90M
Ebit 213.80M 156.40M 31.50M 319.20M 306.20M
Ebitda 329.80M 279.50M 31.50M 484.40M 460.50M
Depreciation and amortization 116.00M 123.10M 162.60M 165.20M 154.30M
Non operating income net other - - - 3.10M 2.40M
Operating income 225.70M -1038.20M 31.50M 319.20M 306.20M
Other operating expenses 2493.80M 3548.80M 3402.70M 2249.90M 2202.70M
Interest expense 36.60M 46.40M 63.40M 38.40M 54.10M
Tax provision 130.20M 33.90M 45.10M 45.90M -9.00M
Net interest income -36.60M -46.40M -64.00M -38.40M -54.10M
Income tax expense 130.20M 33.90M 45.30M 45.90M -9.00M
Total revenue 2719.50M 2510.60M 2566.50M 2569.10M 2508.90M
Total operating expenses 1270.60M 2429.80M 1150.70M 1155.60M 1120.30M
Cost of revenue 1223.20M 1119.00M 2252.00M 1094.30M 1082.40M
Total other income expense net -48.50M -46.50M -86.40M -35.30M -51.70M
Discontinued operations - - - 5.10M 77.00M
Net income from continuing ops 47.00M -1118.60M 190.70M 238.00M 263.50M
Net income applicable to common shares - - - 243.10M 340.50M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 5679.00M 5350.50M 6605.10M 6587.00M 6574.20M
Intangible assets 627.20M 649.90M 954.00M 1086.70M 1046.40M
Other current assets 97.20M 115.20M 137.40M 123.40M 154.30M
Total liab 2572.70M 2415.70M 2431.20M 2380.10M 2516.20M
Total stockholder equity 3106.30M 2934.80M 4173.90M 4206.90M 4057.60M
Other current liab 437.20M 348.80M 309.40M 392.50M 505.80M
Common stock 1.80M 1.70M 1.70M 1.60M 1.60M
Capital stock 1.80M 1.70M 1.70M 1.60M 1.60M
Retained earnings -440.40M -487.40M 631.20M 731.40M 466.90M
Other liab - - - 151.30M 304.60M
Good will 2358.20M 2261.90M 3292.20M 3496.60M 3132.00M
Other assets - - - 153.70M 167.80M
Cash 1211.70M 1069.10M 940.00M 606.90M 1073.60M
Total current liabilities 852.60M 878.70M 780.80M 1236.70M 1207.80M
Current deferred revenue 184.80M 146.50M 106.40M 78.90M 60.10M
Net debt 386.00M 478.60M 713.60M 922.20M 386.30M
Short term debt 39.00M 150.50M 145.60M 537.00M 456.10M
Short long term debt - 116.00M 115.30M 510.00M 432.40M
Short long term debt total 1597.70M 1547.70M 1653.60M 1529.10M 1459.90M
Other stockholder equity 3658.10M 3791.60M 3758.20M 3699.00M 3732.60M
Property plant equipment - - - 293.60M 392.20M
Total current assets 2026.60M 1788.30M 1743.70M 1424.60M 1835.80M
Net tangible assets - - - 3241.60M -120.80M
Net receivables 429.60M 363.00M 407.50M 393.50M 331.90M
Long term debt 1448.30M 1278.30M 1398.10M 870.70M 883.40M
Inventory 288.10M 241.00M 258.80M 300.80M 263.80M
Accounts payable 191.60M 174.60M 179.50M 228.30M 185.80M
Noncontrolling interest in consolidated entity - - - - 0.40M
Accumulated other comprehensive income -113.20M -371.10M -217.20M -225.10M -143.50M
Common stock total equity - - - 1.60M 1.60M
Retained earnings total equity - - - 731.40M 466.90M
Non currrent assets other 228.10M 204.20M 180.50M 153.70M 167.80M
Non current assets total 3652.40M 3562.20M 4861.40M 5162.40M 4738.40M
Capital lease obligations 149.40M 153.40M 140.20M 148.40M 144.10M
Long term debt total - - - 870.70M 883.40M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.50M -54.60M -50.90M -657.30M 232.90M
Change to liabilities - - - -88.50M -79.30M
Total cashflows from investing activities -51.10M -54.60M -62.40M -657.30M 232.90M
Net borrowings -0.90M -100.00M 133.70M -0.20M -475.70M
Total cash from financing activities -170.90M -103.70M 118.90M 12.50M -465.60M
Change to operating activities - - - -176.30M 15.10M
Net income 47.00M -1118.60M -100.20M 243.10M 340.50M
Change in cash 142.60M 129.10M 333.10M -466.70M 184.70M
Begin period cash flow 1069.10M 940.00M 606.90M 1073.60M 888.90M
End period cash flow 1211.70M 1069.10M 940.00M 606.90M 1073.60M
Total cash from operating activities 275.70M 336.50M 275.70M 182.70M 391.40M
Issuance of capital stock - - - - 0.00M
Depreciation 150.70M 154.50M 162.60M 162.10M 151.90M
Other cashflows from investing activities -6.30M 2.30M -14.90M -637.60M -4.60M
Change to inventory -29.10M 3.60M 35.10M -39.90M -66.00M
Change to account receivables -48.50M 10.00M -17.00M -71.00M -43.20M
Sale purchase of stock -166.60M 0.00M -7.90M 21.80M 19.50M
Other cashflows from financing activities -6.20M -6.10M -7.80M 137.00M 10.10M
Change to netincome - - - 6.60M 49.10M
Capital expenditures 45.30M 33.80M 58.20M 75.70M 54.70M
Change receivables - - - -71.00M -43.20M
Cash flows other operating - - - -9.50M -20.70M
Cash and cash equivalents changes - - - -462.10M 158.70M
Change in working capital 8.90M 97.40M -108.40M -271.70M -173.40M
Stock based compensation 37.60M 35.30M 30.70M 30.50M 28.20M
Other non cash items 20.10M 1196.90M 328.00M 47.70M 34.10M
Free cash flow 230.40M 302.70M 217.50M 107.00M 336.70M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NVST
Envista Holdings Corp		 0.21
0.84%		 25.17 44.16 20.33 1.39 1.35 1.61 10.94
ISRG
Intuitive Surgical Inc		 -15.72
3.36%		 452.80 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 2.75
1.29%		 215.85 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 0.92
0.86%		 107.77 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 -1.69
0.79%		 211.86 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Building E, Brea, CA, United States, 92821-6208

714 817 7000

https://envistaco.com

12000

Name Title Year Born
Mr. Amir Aghdaei Pres, CEO & Director 1959
Mr. Howard H. Yu Sr. VP & CFO 1973
Mr. Mark E. Nance Sr. VP, Gen. Counsel & Sec. 1969
Mr. Patrik Eriksson Sr. VP & Pres of Nobel Biocare 1968
Mr. Jean-Claude E. Kyrillos Sr. VP and Pres of Diagnostics & Digital Solutions 1964
Juan Arbona Chief Compliance Officer NA
Mr. Mischa M. Reis Sr. VP of Strategy & Corp. Devel. 1973
Mr. Filippo Impieri Sr. VP of Emerging Markets NA
Ms. Claudia Ortiz Sr. VP of Regulatory Affairs & Quality Assurance NA
Mr. Eric Conley Sr. VP of Orthodontics NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…